FDA: Drugmakers have not made good on promised studies

04/24/2008 | Bloomberg1

A federal report found that drugmakers, as of Sept. 30, had not begun 1,044 post-market drug studies that they pledged to the FDA they would perform. Promises for 444 of them date back to Oct. 1, 2004, or earlier. A spokeswoman for the FDA said it will make sure that drug firms finish the incomplete post-approval trials "in a timely manner."

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC